Showing results (921-930 of 1,194) with videos related to

Sort By:
Pageof 120
Nature Biotechnology|May 1, 2012
Absolute quantification of somatic DNA alterations in human cancerScott L Carter, Kristian Cibulskis, Elena Helman, et al.
Cancer Research|September 26, 2013
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerizationJeonghee Cho, Liang Chen, Naveen Sangji, et al.
JMIR Mhealth and Uhealth|November 11, 2020
Opportunities for Mobile App-Based Adherence Support for Children With Tuberculosis in South AfricaRachel M Morse, Hanlie Myburgh, David Reubi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancerChang-Qi Zhu, Keyue Ding, Dan Strumpf, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumorVeit J Scheble, Martin Braun, Rameen Beroukhim, et al.
Cancer Discovery|May 16, 2012
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancersHihu Wing Cheung, Jinyan Du, Jesse S Boehm, et al.
Lung Cancer (Amsterdam, Netherlands)|February 21, 2012
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencingDaniela S Basseres, Francesco D'Alò, Beow Y Yeap, et al.
Cancer Research|May 28, 2009
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidneyRameen Beroukhim, Jean-Philippe Brunet, Arianna Di Napoli, et al.
Molecular Cell|August 21, 2020
Structural Basis of the Activation of Heterotrimeric Gs-Protein by Isoproterenol-Bound β1-Adrenergic ReceptorMinfei Su, Lan Zhu, Yixiao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemiaBrenda W Cooper, Gareth J Veal, Tomas Radivoyevitch, et al.
Pageof 120